VOLume and Vasopressor Therapy in Patients With Hemodynamic instAbility
VOLTA
Characterizing VOLume and Vasopressor Therapy in Patients With Hemodynamic instAbility (VOLTA)
1 other identifier
observational
125
1 country
1
Brief Summary
This prospective observational study will include critically ill patients with hemodynamic compromise. It will compare passive leg raising and a mini volume challenge (MVC) carried out on every patient sequentially. The endogenous release of stress hormones will also be assayed in order to investigate their modifying effect on the hemodynamic reaction of the participants. The effect of fluid resuscitation on renal perfusion will also be assessed and the data compared with the release of cystatin C.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2019
CompletedFirst Submitted
Initial submission to the registry
September 3, 2019
CompletedFirst Posted
Study publicly available on registry
September 13, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedJune 30, 2022
June 1, 2022
1.9 years
September 3, 2019
June 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in blood pressure under PLR vs. MVC
changes in mean arterial pressure with PLR vs. MVC
immediately at the end of the MVC
Secondary Outcomes (4)
Hemodynamic changes with PLR vs. MVC
immediately at the end of the MVC
fluid requirement and endogenous stress response
at the end of the first 3 hours of fluid resuscitation
fluid administration versus renal perfusion
1 and 24 hours after initial fluid resuscitation
fluid administration and capillary leak
at the end of the first 3 hours of fluid resuscitation
Interventions
Blood samples will be collected and ultrasound evaluation of renal perfusion conducted in study participants immediately before conducting passive leg raising (PLR). PLR will then be carried out on study participants, followed by MVC. PLR- and/or MVC-responsive patients will receive a further 700 ml fluid immediately after the MVC. Renal perfusion will be further assessed 1 and 24 hours after the MVC.
Eligibility Criteria
critically ill adult medical patients with signs of hemodynamic instability
You may qualify if:
- mean arterial pressure \<65 mm Hg and/or
- blood lactate \>2 mmol/l and/or
- mottling or capillary refill \>3 seconds and/or
- oliguria and
- critical care decision for testing fluid responsiveness
You may not qualify if:
- cardiopulmonary resuscitation
- uncontrolled bleeding
- irreversible brain damage
- pregnancy and lactation
- Age under 18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital of Leipzig
Leipzig, Saxony, D-04103, Germany
Biospecimen
norepinephrine renin copeptin A cortisol angiopoietin-2 cystatin C
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Sirak Petros, MD
University Hospital of Leipzig, Medical ICU
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 3, 2019
First Posted
September 13, 2019
Study Start
September 1, 2019
Primary Completion
July 31, 2021
Study Completion
September 30, 2021
Last Updated
June 30, 2022
Record last verified: 2022-06